Minipress Xl

   
Google
 
Web NewDrugInformation.com

Minipress Xl


Drug - Minipress Xl
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Prazosin Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 2.5MG
The potency of the active ingredient(s), Prazosin Hydrochloride. May repeat for multiple part products.

Applicant - PFIZER
The firm name holding legal responsibility for Minipress Xl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019775
The FDA assigned number to Minipress Xl. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Minipress Xl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 29, 1992
The date Minipress Xl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Minipress Xl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Minipress Xl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pfizer Inc
The full name of the firm holding legal responsibility for the new application of Minipress Xl.

Minipress Xl